Premium
FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening ,
Author(s) -
Jauniaux Eric,
Bhide Amar,
Kennedy Anne,
Woodward Paula,
Hubit Corrine,
Collins Sally
Publication year - 2018
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.12408
Subject(s) - medicine , placenta accreta , obstetrics and gynaecology , obstetrics , population , university hospital , gynecology , family medicine , pregnancy , placenta , fetus , environmental health , biology , genetics
Recent population studies have shown that placenta accreta spectrum (PAS) disorders remain undiagnosed before delivery in half to two-thirds of cases. In a series from specialist diagnostic units in the USA, around onethird of cases of PAS disorders were not diagnosed during pregnancy. Maternal mortality and morbidity are reduced when women with PAS disorders, particularly the invasive forms—placenta increta or percreta—deliver in a center of excellence by a multidisciplinary care team with experience in managing the surgical risks and perioperative challenges presented by these disorders. Transfer to a center of excellence, however, relies on both recognition of the women at risk of PAS disorders and on accurate prenatal diagnosis.